Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1997 Jun;65(6):2396–2401. doi: 10.1128/iai.65.6.2396-2401.1997

Broad-spectrum antimicrobial activity of human intestinal defensin 5.

E M Porter 1, E van Dam 1, E V Valore 1, T Ganz 1
PMCID: PMC175332  PMID: 9169780

Abstract

Defensins are antibiotic peptides expressed in human and animal myeloid and epithelial cells. Due to the limited availability of natural peptides, the properties of human epithelial defensins have not been studied. We assayed the microbicidal activity of recombinant human intestinal defensin 5 (rHD-5) in the presence of salt (O to 150 mM NaCl) with varied pH (pH 5.5 to pH 8.5) and trypsin (25 and 250 microg/ml). rHD-5 exhibits microbicidal activity against Listeria monocytogenes, Escherichia coli, and Candida albicans. In contrast to cryptdins, the mouse intestinal defensins, rHD-5 is active against both mouse-virulent wild-type Salmonella typhimurium and its isogenic, mouse-avirulent phoP mutant. In the presence of salt, rHD-5 activity was reduced, and at 100 mM NaCl, activity against S. typhimurium was abolished. However, at all salt concentrations tested, rHD-5 remained bactericidal to L. monocytogenes. Activity against L. monocytogenes was not pH dependent but was diminished at pH 5.5 against wild-type S. typhimurium. This acid-induced resistance may have been mediated by the virulence gene regulator phoP, since the phoP mutant was equally sensitive at pH 5.5 and pH 7.4. In the presence of trypsin, rHD-5 was partially cleaved, but even then, rHD-5 at 100 microg/ml decreased the number of CFU of wild-type S. typhimurium by more than 99%. The persistence of microbicidal activity of rHD-5 under these conditions supports the notion that naturally occurring human intestinal defensin is an effective arm of mucosal host defense.

Full Text

The Full Text of this article is available as a PDF (401.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aley S. B., Zimmerman M., Hetsko M., Selsted M. E., Gillin F. D. Killing of Giardia lamblia by cryptdins and cationic neutrophil peptides. Infect Immun. 1994 Dec;62(12):5397–5403. doi: 10.1128/iai.62.12.5397-5403.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Alpuche Aranda C. M., Swanson J. A., Loomis W. P., Miller S. I. Salmonella typhimurium activates virulence gene transcription within acidified macrophage phagosomes. Proc Natl Acad Sci U S A. 1992 Nov 1;89(21):10079–10083. doi: 10.1073/pnas.89.21.10079. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bearson S. M., Benjamin W. H., Jr, Swords W. E., Foster J. W. Acid shock induction of RpoS is mediated by the mouse virulence gene mviA of Salmonella typhimurium. J Bacteriol. 1996 May;178(9):2572–2579. doi: 10.1128/jb.178.9.2572-2579.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Behlau I., Miller S. I. A PhoP-repressed gene promotes Salmonella typhimurium invasion of epithelial cells. J Bacteriol. 1993 Jul;175(14):4475–4484. doi: 10.1128/jb.175.14.4475-4484.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bensch K. W., Raida M., Mägert H. J., Schulz-Knappe P., Forssmann W. G. hBD-1: a novel beta-defensin from human plasma. FEBS Lett. 1995 Jul 17;368(2):331–335. doi: 10.1016/0014-5793(95)00687-5. [DOI] [PubMed] [Google Scholar]
  6. Berkowitz B. A., Bevins C. L., Zasloff M. A. Magainins: a new family of membrane-active host defense peptides. Biochem Pharmacol. 1990 Feb 15;39(4):625–629. doi: 10.1016/0006-2952(90)90138-b. [DOI] [PubMed] [Google Scholar]
  7. Bessalle R., Haas H., Goria A., Shalit I., Fridkin M. Augmentation of the antibacterial activity of magainin by positive-charge chain extension. Antimicrob Agents Chemother. 1992 Feb;36(2):313–317. doi: 10.1128/aac.36.2.313. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Bevins C. L., Zasloff M. Peptides from frog skin. Annu Rev Biochem. 1990;59:395–414. doi: 10.1146/annurev.bi.59.070190.002143. [DOI] [PubMed] [Google Scholar]
  9. Bohe M., Borgström A., Lindström C., Ohlsson K. Pancreatic endoproteases and pancreatic secretory trypsin inhibitor immunoreactivity in human Paneth cells. J Clin Pathol. 1986 Jul;39(7):786–793. doi: 10.1136/jcp.39.7.786. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Clancy R., Pang G., Dunkley M., Taylor D., Cripps A. Acute on chronic bronchitis: A model of mucosal immunology. Immunol Cell Biol. 1995 Oct;73(5):414–417. doi: 10.1038/icb.1995.64. [DOI] [PubMed] [Google Scholar]
  11. Daher K. A., Selsted M. E., Lehrer R. I. Direct inactivation of viruses by human granulocyte defensins. J Virol. 1986 Dec;60(3):1068–1074. doi: 10.1128/jvi.60.3.1068-1074.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Diamond G., Russell J. P., Bevins C. L. Inducible expression of an antibiotic peptide gene in lipopolysaccharide-challenged tracheal epithelial cells. Proc Natl Acad Sci U S A. 1996 May 14;93(10):5156–5160. doi: 10.1073/pnas.93.10.5156. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Diamond G., Zasloff M., Eck H., Brasseur M., Maloy W. L., Bevins C. L. Tracheal antimicrobial peptide, a cysteine-rich peptide from mammalian tracheal mucosa: peptide isolation and cloning of a cDNA. Proc Natl Acad Sci U S A. 1991 May 1;88(9):3952–3956. doi: 10.1073/pnas.88.9.3952. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Edelman K., Valenzuela J. E. Effect of intravenous lipid on human pancreatic secretion. Gastroenterology. 1983 Nov;85(5):1063–1066. [PubMed] [Google Scholar]
  15. Eisenhauer P. B., Harwig S. S., Lehrer R. I. Cryptdins: antimicrobial defensins of the murine small intestine. Infect Immun. 1992 Sep;60(9):3556–3565. doi: 10.1128/iai.60.9.3556-3565.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Eisenhauer P. B., Harwig S. S., Szklarek D., Ganz T., Selsted M. E., Lehrer R. I. Purification and antimicrobial properties of three defensins from rat neutrophils. Infect Immun. 1989 Jul;57(7):2021–2027. doi: 10.1128/iai.57.7.2021-2027.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Evans D. F., Pye G., Bramley R., Clark A. G., Dyson T. J., Hardcastle J. D. Measurement of gastrointestinal pH profiles in normal ambulant human subjects. Gut. 1988 Aug;29(8):1035–1041. doi: 10.1136/gut.29.8.1035. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Fallingborg J., Christensen L. A., Ingeman-Nielsen M., Jacobsen B. A., Abildgaard K., Rasmussen H. H., Rasmussen S. N. Measurement of gastrointestinal pH and regional transit times in normal children. J Pediatr Gastroenterol Nutr. 1990 Aug;11(2):211–214. doi: 10.1097/00005176-199008000-00010. [DOI] [PubMed] [Google Scholar]
  19. Ganz T., Lehrer R. I. Defensins. Curr Opin Immunol. 1994 Aug;6(4):584–589. doi: 10.1016/0952-7915(94)90145-7. [DOI] [PubMed] [Google Scholar]
  20. Ganz T., Selsted M. E., Szklarek D., Harwig S. S., Daher K., Bainton D. F., Lehrer R. I. Defensins. Natural peptide antibiotics of human neutrophils. J Clin Invest. 1985 Oct;76(4):1427–1435. doi: 10.1172/JCI112120. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Garcia Véscovi E., Soncini F. C., Groisman E. A. The role of the PhoP/PhoQ regulon in Salmonella virulence. Res Microbiol. 1994 Jun-Aug;145(5-6):473–480. doi: 10.1016/0923-2508(94)90096-5. [DOI] [PubMed] [Google Scholar]
  22. Geboes K., Van den Oord J. J., Rutgeerts P., Desmet V. J., Vantrappen G. Immunohistochemical identification of lysozyme in pseudopyloric gland metaplasia in Crohn's disease. Hepatogastroenterology. 1983 Aug;30(4):158–160. [PubMed] [Google Scholar]
  23. Groisman E. A., Parra-Lopez C., Salcedo M., Lipps C. J., Heffron F. Resistance to host antimicrobial peptides is necessary for Salmonella virulence. Proc Natl Acad Sci U S A. 1992 Dec 15;89(24):11939–11943. doi: 10.1073/pnas.89.24.11939. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Harwig S. S., Tan L., Qu X. D., Cho Y., Eisenhauer P. B., Lehrer R. I. Bactericidal properties of murine intestinal phospholipase A2. J Clin Invest. 1995 Feb;95(2):603–610. doi: 10.1172/JCI117704. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Jones D. E., Bevins C. L. Defensin-6 mRNA in human Paneth cells: implications for antimicrobial peptides in host defense of the human bowel. FEBS Lett. 1993 Jan 4;315(2):187–192. doi: 10.1016/0014-5793(93)81160-2. [DOI] [PubMed] [Google Scholar]
  26. Jones D. E., Bevins C. L. Paneth cells of the human small intestine express an antimicrobial peptide gene. J Biol Chem. 1992 Nov 15;267(32):23216–23225. [PubMed] [Google Scholar]
  27. Kagan B. L., Selsted M. E., Ganz T., Lehrer R. I. Antimicrobial defensin peptides form voltage-dependent ion-permeable channels in planar lipid bilayer membranes. Proc Natl Acad Sci U S A. 1990 Jan;87(1):210–214. doi: 10.1073/pnas.87.1.210. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Karem K., Foster J. W. The influence of DNA topology on the environmental regulation of a pH-regulated locus in Salmonella typhimurium. Mol Microbiol. 1993 Oct;10(1):75–86. doi: 10.1111/j.1365-2958.1993.tb00905.x. [DOI] [PubMed] [Google Scholar]
  29. Layer P., Schlesinger T., Gröger G., Goebell H. Modulation of human periodic interdigestive gastrointestinal motor and pancreatic function by the ileum. Pancreas. 1993 Jul;8(4):426–432. doi: 10.1097/00006676-199307000-00004. [DOI] [PubMed] [Google Scholar]
  30. Lehrer R. I., Barton A., Daher K. A., Harwig S. S., Ganz T., Selsted M. E. Interaction of human defensins with Escherichia coli. Mechanism of bactericidal activity. J Clin Invest. 1989 Aug;84(2):553–561. doi: 10.1172/JCI114198. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Lehrer R. I., Lichtenstein A. K., Ganz T. Defensins: antimicrobial and cytotoxic peptides of mammalian cells. Annu Rev Immunol. 1993;11:105–128. doi: 10.1146/annurev.iy.11.040193.000541. [DOI] [PubMed] [Google Scholar]
  32. Lehrer R. I., Rosenman M., Harwig S. S., Jackson R., Eisenhauer P. Ultrasensitive assays for endogenous antimicrobial polypeptides. J Immunol Methods. 1991 Mar 21;137(2):167–173. doi: 10.1016/0022-1759(91)90021-7. [DOI] [PubMed] [Google Scholar]
  33. Levay P. F., Viljoen M. Lactoferrin: a general review. Haematologica. 1995 May-Jun;80(3):252–267. [PubMed] [Google Scholar]
  34. Martin E., Ganz T., Lehrer R. I. Defensins and other endogenous peptide antibiotics of vertebrates. J Leukoc Biol. 1995 Aug;58(2):128–136. doi: 10.1002/jlb.58.2.128. [DOI] [PubMed] [Google Scholar]
  35. McCloy R. F., Greenberg G. R., Baron J. H. Duodenal pH in health and duodenal ulcer disease: effect of a meal, Coca-Cola, smoking, and cimetidine. Gut. 1984 Apr;25(4):386–392. doi: 10.1136/gut.25.4.386. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Miller S. I. PhoP/PhoQ: macrophage-specific modulators of Salmonella virulence? Mol Microbiol. 1991 Sep;5(9):2073–2078. doi: 10.1111/j.1365-2958.1991.tb02135.x. [DOI] [PubMed] [Google Scholar]
  37. Miller S. I., Pulkkinen W. S., Selsted M. E., Mekalanos J. J. Characterization of defensin resistance phenotypes associated with mutations in the phoP virulence regulon of Salmonella typhimurium. Infect Immun. 1990 Nov;58(11):3706–3710. doi: 10.1128/iai.58.11.3706-3710.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Minami T., Tojo H., Shinomura Y., Matsuzawa Y., Okamoto M. Purification and characterization of a phospholipase A2 from human ileal mucosa. Biochim Biophys Acta. 1993 Oct 13;1170(2):125–130. [PubMed] [Google Scholar]
  39. Miyakawa Y., Ratnakar P., Rao A. G., Costello M. L., Mathieu-Costello O., Lehrer R. I., Catanzaro A. In vitro activity of the antimicrobial peptides human and rabbit defensins and porcine leukocyte protegrin against Mycobacterium tuberculosis. Infect Immun. 1996 Mar;64(3):926–932. doi: 10.1128/iai.64.3.926-932.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Miyasaki K. T., Bodeau A. L., Ganz T., Selsted M. E., Lehrer R. I. In vitro sensitivity of oral, gram-negative, facultative bacteria to the bactericidal activity of human neutrophil defensins. Infect Immun. 1990 Dec;58(12):3934–3940. doi: 10.1128/iai.58.12.3934-3940.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Molmenti E. P., Perlmutter D. H., Rubin D. C. Cell-specific expression of alpha 1-antitrypsin in human intestinal epithelium. J Clin Invest. 1993 Oct;92(4):2022–2034. doi: 10.1172/JCI116797. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Nevalainen T. J., Grönroos J. M., Kallajoki M. Expression of group II phospholipase A2 in the human gastrointestinal tract. Lab Invest. 1995 Feb;72(2):201–208. [PubMed] [Google Scholar]
  43. Ouellette A. J., Hsieh M. M., Nosek M. T., Cano-Gauci D. F., Huttner K. M., Buick R. N., Selsted M. E. Mouse Paneth cell defensins: primary structures and antibacterial activities of numerous cryptdin isoforms. Infect Immun. 1994 Nov;62(11):5040–5047. doi: 10.1128/iai.62.11.5040-5047.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Ouellette A. J., Miller S. I., Henschen A. H., Selsted M. E. Purification and primary structure of murine cryptdin-1, a Paneth cell defensin. FEBS Lett. 1992 Jun 15;304(2-3):146–148. doi: 10.1016/0014-5793(92)80606-h. [DOI] [PubMed] [Google Scholar]
  45. Porter E. M., Liu L., Oren A., Anton P. A., Ganz T. Localization of human intestinal defensin 5 in Paneth cell granules. Infect Immun. 1997 Jun;65(6):2389–2395. doi: 10.1128/iai.65.6.2389-2395.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Rao A. G., Rood T., Maddox J., Duvick J. Synthesis and characterization of defensin NP-1. Int J Pept Protein Res. 1992 Dec;40(6):507–514. doi: 10.1111/j.1399-3011.1992.tb00434.x. [DOI] [PubMed] [Google Scholar]
  47. Russell J. P., Diamond G., Tarver A. P., Scanlin T. F., Bevins C. L. Coordinate induction of two antibiotic genes in tracheal epithelial cells exposed to the inflammatory mediators lipopolysaccharide and tumor necrosis factor alpha. Infect Immun. 1996 May;64(5):1565–1568. doi: 10.1128/iai.64.5.1565-1568.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Schonwetter B. S., Stolzenberg E. D., Zasloff M. A. Epithelial antibiotics induced at sites of inflammation. Science. 1995 Mar 17;267(5204):1645–1648. doi: 10.1126/science.7886453. [DOI] [PubMed] [Google Scholar]
  49. Schwab I. R., Dries D., Cullor J., Smith W., Mannis M., Reid T., Murphy C. J. Corneal storage medium preservation with defensins. Cornea. 1992 Sep;11(5):370–375. doi: 10.1097/00003226-199209000-00002. [DOI] [PubMed] [Google Scholar]
  50. Selsted M. E., Harwig S. S. Determination of the disulfide array in the human defensin HNP-2. A covalently cyclized peptide. J Biol Chem. 1989 Mar 5;264(7):4003–4007. [PubMed] [Google Scholar]
  51. Selsted M. E., Miller S. I., Henschen A. H., Ouellette A. J. Enteric defensins: antibiotic peptide components of intestinal host defense. J Cell Biol. 1992 Aug;118(4):929–936. doi: 10.1083/jcb.118.4.929. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Selsted M. E., Szklarek D., Ganz T., Lehrer R. I. Activity of rabbit leukocyte peptides against Candida albicans. Infect Immun. 1985 Jul;49(1):202–206. doi: 10.1128/iai.49.1.202-206.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Shimoda M., Ohki K., Shimamoto Y., Kohashi O. Morphology of defensin-treated Staphylococcus aureus. Infect Immun. 1995 Aug;63(8):2886–2891. doi: 10.1128/iai.63.8.2886-2891.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Tang Y. Q., Selsted M. E. Characterization of the disulfide motif in BNBD-12, an antimicrobial beta-defensin peptide from bovine neutrophils. J Biol Chem. 1993 Mar 25;268(9):6649–6653. [PubMed] [Google Scholar]
  55. Watson B. W., Meldrum S. J., Riddle H. C., Brown R. L., Sladen G. E. pH profile of gut as measured by radiotelemetry capsule. Br Med J. 1972 Apr 8;2(5805):104–106. doi: 10.1136/bmj.2.5805.104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Wimley W. C., Selsted M. E., White S. H. Interactions between human defensins and lipid bilayers: evidence for formation of multimeric pores. Protein Sci. 1994 Sep;3(9):1362–1373. doi: 10.1002/pro.5560030902. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Yasin B., Harwig S. S., Lehrer R. I., Wagar E. A. Susceptibility of Chlamydia trachomatis to protegrins and defensins. Infect Immun. 1996 Mar;64(3):709–713. doi: 10.1128/iai.64.3.709-713.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES